pharma · Chronic kidney disease · Advanced solid tumors
Bayer
Bayer AG
Bayer clinical programs — 24 development programs from ClinicalTrials.gov with phase, modality, indication, and trial identifiers.
Company details
- Status
- Public
- HQ
- Kaiser-Wilhelm-Allee, Leverkusen, North Rhine-Westphalia 51373, DE
- Employees
- 97,894
- Programs
- 47
- Drugs
- 62
- Patents
- 5
Bayer projects
24 ClinicalTrials.gov programs sponsored by Bayer.
Bayer has 24 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
Clinical programs
-
20511
Bayer AG
Prostate cancer
1 trial -
21820
Bayer AG
Advanced solid tumors
1 trial -
21948
Bayer AG
Advanced solid tumors
1 trial -
22127
Bayer AG
Chronic kidney disease
1 trial -
22128
Bayer AG
Chronic kidney disease
1 trial -
22231
Bayer AG
Advanced solid tumors, Non-small cell lung cancer
1 trial -
22262
Bayer AG
hepatocellular carcinoma (HCC)
1 trial -
22265
Bayer AG
Coagulopathy, Sepsis
1 trial -
22342
Bayer AG
Heart failure in children
1 trial -
22375
Bayer AG
Prevention of ischemic stroke in patients after an acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack in combination with antiplatelet therapy
1 trial -
22534
Bayer AG
Onchocerciasis (river blindness): is an infectious disease caused by Onchocerca volvulus, a parasitic nematode worm. The disease is contracted through the bite of an infected blackfly of the genus Simulium, which transmits third-stage infective larvae. An estimated 18 million people suffer from onchocerciasis, with 99% cases in 31 African countries, and 187 million people at risk Onchocercal dermatitis is the most common symptom of the disease, but severe visual impairment and blindness are the most severe complication, and onchocerciasis is the world’s second-leading infectious cause of blindness. Programs for the treatment and control of onchocerciasis through mass drug administration of ivermectin have been in place for over 20 years. However, they require patients to be given treatment (ivermectin) at regular intervals for the life of the adult worm (up to 15 years), making implementation extremely difficult in endemic countries. Emodepside is a registered drug for animal health, marketed by Bayer Animal Health GmbH under the name of Profender® (in combination with praziquantel) or Procox® (in combination with toltrazuril). It is a cyclooctadepsipeptide anthelmintic drug., Soil-transmitted helminth infection: Soil-transmitted helminthiasis is caused by one of the three soil-transmitted helminths (STH), Ascaris lumbricoides, Trichuris trichiura and hookworm (Ancylostoma duodenale and Necator americanus). Currently, STH still infects about 1.5 billion people worldwide, mostly in tropical and subtropical regions. Emodepside is a registered drug for animal health, marketed by Bayer Animal Health GmbH under the name of Profender® (in combination with praziquantel) or Procox® (in combination with toltrazuril). It is a cyclooctadepsipeptide anthelmintic drug.
1 trial -
22537
Bayer AG
Soil-transmitted helminth infection, Onchocerciasis (river blindness)
1 trial -
22597
Bayer AG
Chronic kidney disease, Coronary artery disease
1 trial -
22598
Bayer AG
Chronic Kidney Disease, Arterial hypertension
1 trial -
22600
Bayer AG
Chronic Kidney Disease
1 trial -
22665
Bayer AG
Prevention of ischemic stroke in patients post acute non-cardioembolic ischemic stroke or high-risk transient ischemic attack
1 trial -
22676
Bayer AG
Advanced solid tumors harboring KRAS G12C mutation
1 trial -
22700
Bayer AG
Chronic Kidney Disease
1 trial -
22723
Bayer AG
Chronic kidney disease
1 trial -
22806
Bayer AG
atrial fibrillation, transient ischemic attack (TIA), ischemic stroke
1 trial -
22819
Bayer AG
Cardiac arrhythmia
1 trial -
22967
Bayer AG
Vasodilatory shock
1 trial -
A study to learn how safe the study drug BAY... for Advanced solid tumors
Bayer AG
Advanced solid tumors
1 trial -
Asundexian Bayer 10mg Granules, BAY 2433334
Bayer AG
Prevention of thromboembolic events
1 trial
Frequently asked questions
How many clinical projects does Bayer have?
24 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This directory lists published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.